Show simple item record

dc.contributor.authorTokhmechian, Laleh
dc.date.accessioned2021-11-30T06:40:57Z
dc.date.available2021-11-30T06:40:57Z
dc.date.issued2021en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/65574
dc.description.abstractThe aim of this study was to evaluate the pharmacological methods such as alendronate administration of bisphosphonates and its effect on osteopenia in patients. Materials and Methods: In this study, 30 patients with acute leukemia were prescribed alendronate for six months with the chemical compound alendronate sodium and its effect on bone density by scanning bone densitometry and blood levels of calcium, phosphorus, vitamin D and alkaline Phosphatase. Results: After receiving alendronate, Z-score of lumbar vertebrae was 1.14 before 6 months, which after 6 months Z-score was 1.21 with (P = 0.409), which made a statistically significant difference. Did not. As a result, alendronate did not affect the incidence of acute leukemia osteopenia.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/65573en_US
dc.subjectLeukemiaen_US
dc.subjectosteopeniaen_US
dc.subjectbone densitometry scanen_US
dc.titleThe Evaluation of The effects of Alendronates on Osteopenia in Children with Acute Leukemiaen_US
dc.typeThesisen_US
dc.contributor.supervisorRezamand, Azim
dc.contributor.supervisorShiva, Siyamak
dc.identifier.docno6010133en_US
dc.identifier.callno10133en_US
dc.description.disciplinePediatricsen_US
dc.description.degreeSpecialty Degreeen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record